Latest Posts
About This Stock
More About This Stock
Read
Read
ChemoCentryx's Lead Drug Meets Phase II Objective; Novartis Reports Results Of Trial Evaluating Use Of Afinitor

Article By:
BioMedReports
Friday, December 12, 2014 3:13 PM EST
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 12, 2014.
APRI Announces First Patient Enrolled In Phase 2a Trial For RayVa; Keryx Announces Issuance Of New U.S. Patent For Auryxia

Article By:
BioMedReports
Thursday, December 4, 2014 8:25 PM EST
A look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014, including APRI, KERX, ALDX, CCXI